Biogen valuation
Valuation
The P/E ratio is 107.2. The average price target of 32 analysts is $268.26.
Data as of November 18, 2026
Biogen compared with similar companies
Biogen's P/E (trailing 12 months): 107.2, +155% against the median of a group of 10 similar companies (42.1).
| Metric | Biogen | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 107.2 | 42.1 | 20.8 – 49.4 | High |
| Forward P/E | 15.4 | 18.1 | 15.8 – 22.0 | Low |
| EV/EBITDA | 13.2 | 13.9 | 11.8 – 17.5 | Middle |
| Price/book | 1.96 | 6.65 | 2.27 – 14.2 | Low |
| Price/sales | 3.60 | 5.29 | 2.55 – 6.83 | Middle |
| Gross margin | 75.8% | 73.7% | 71.6% – 75.5% | High |
| Operating margin | 23.5% | 32.4% | 25.0% – 35.9% | Low |
| Net margin | 3.4% | 14.4% | 5.0% – 17.3% | Low |
| ROE | 1.9% | 15.1% | 4.6% – 38.0% | Low |
| Debt/equity | 0.41 | 0.95 | 0.45 – 1.74 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Biogen: valuation over time
On the latest fiscal year's earnings (2025), Biogen's P/E today is 28.5, above the median of its last 10 fiscal years (15.3; between 9.44 and 32.5 from 2016 to 2025). Relative to earnings, the stock costs more than it used to.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | $175.99 | $8.79 | 20.0 |
| 2024 | $152.92 | $11.18 | 13.7 |
| 2023 | $258.77 | $7.97 | 32.5 |
| 2022 | $276.92 | $20.87 | 13.3 |
| 2021 | $239.92 | $10.40 | 23.1 |
| 2020 | $244.86 | $24.80 | 9.87 |
| 2019 | $296.73 | $31.42 | 9.44 |
| 2018 | $300.92 | $21.58 | 13.9 |
| 2017 | $318.57 | $11.92 | 26.7 |
| 2016 | $283.58 | $16.93 | 16.8 |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $37.07B
- Enterprise value
- $43.7B
- PEG
- 3.43
- EV/revenue
- 4.24
Profitability and growth
- ROA
- 4.9%
- ROIC
- 7.4%
- Revenue growth (year over year)
- 10.6%
Financial health
- Total cash
- $1.3B
- Total debt
- $7.8B
- Current ratio
- 1.95
- Quick ratio
- 0.95
- Altman Z-Score
- 2.89
- Piotroski F-Score
- 5.00
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $268.26
- Median price target
- $271.00
- High price target
- $350.00
- Low price target
- $175.00
- Analysts with a price target
- 32
- Consensus
- Buy
- Forward EPS
- $16.26
- EPS estimate, current year
- $12.54
Shares and trading
- Beta
- 0.09
- Average volume
- 1.08M
- Shares outstanding
- 147.82M
- Float
- 147.29M
- Institutional ownership
- 100.4%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 4.1%
- Short ratio (days)
- 4.05
